Agitation in Dementia Webinar
November 18 @ 2:00 pm - 3:00 pm UTC+1£5
Agitation in Dementia – exploring the benefits and harms of treatment, and narrow construction of what treatment means
Professor Sube Banerjee from the University of Plymouth will lead this webinar on Thursday 18 November, 2 – 3pm.
He will discuss issues in the drug and non-drug management of agitation in dementia, including emerging data from the SYMBAD trial of mirtazapine for the treatment of agitation in dementia. Sube will also focus on the particular challenges faced in the COVID-19 pandemic and how this has narrowed treatment options and so potentially driven down quality of care.
This event is aimed at professionals working in the dementia field.
Tickets are £5 and will cover the cost of hosting the event, with all proceeds going towards dementia research.
Sube Banerjee is Executive Dean and Professor of Dementia in the Faculty of Health at the University of Plymouth. Trained at St Thomas’ Hospital, The London School of Hygiene and Tropical Medicine, and the Institute of Psychiatry, King’s College London, clinically he works as an old age psychiatrist.
He served as the Department of Health for England’s senior professional advisor on dementia leading the development of its National Dementia Strategy. His research focusses on quality of life and quality of care in dementia and the evaluation of new treatments and services.
He works with industry and governments on health services, policy and strategies to improve health for older adults with complex needs and those with dementia. He has been awarded national and international awards for policy and research in dementia.